Cambridge CARES
Cambridge CARES
  • About Us
    • Overview
    • Facilities
  • Research
    • Cambridge Centre for Carbon Reduction in Chemical Technology (C4T)
    • Centre for Lifelong Learning and Individualised Cognition (CLIC)
      • Working with schools
    • J-Park Simulator
    • Cities Knowledge Graph
    • Accelerated Manufacturing Platform for Engineered Nanomaterials (AMPLE)
    • Pharmaceutical Innovation Programme Singapore (PIPS)
    • Knowledge Graph Driven P2P Energy Trading
    • Cooling Singapore 2.0
    • Completed Projects
  • Publications
    • C4T
    • CLIC
    • eCO2EP
    • Research Reports
  • Intelligent Decarbonisation
  • People
    • Overview
    • Governing Board
    • Scientific Advisors
    • Researchers
    • Corporate Staff
    • Visiting Scientists
    • Alumni
  • Join Us
    • Careers
    • Internships and Studentships
    • Visiting Scientists
  • Outreach
    • Events
    • News
    • Newsletters
    • Shipping Decarbonisation Calculator
  • Contact Us
  • Intranet
Select Page
/ Research / Pharma Innovation Programme Singapore

Pharma Innovation Programme Singapore (PIPS)

 

The Pharma Innovation Programme Singapore (PIPS) is an industry-led platform which aims to synergistically and strategically bring together public sector research capabilities and domain expertise of the pharmaceutical industry to enhance the productivity and operational efficiency within Singapore’s pharmaceutical sector through leveraging novel manufacturing technologies and data analytics.

CARES has three collaborations with PIPS.

 

Development of Multi-Step Processes in Pharma

With funding from PIPS via A*STAR

Development of Multi-Step Processes in Pharma is led by Professor Alexei Lapkin. This is a three-year project which commenced in June 2019.

Project summary: For a given active pharmaceutical ingredient (API), the complexity of the multi-step chemical synthesis and purification, and the enormous number of possible reagent and reaction condition combinations are significant bottlenecks for rapid large-scale manufacturing. This project focuses on developing a novel automated self-optimising system that can rapidly identify sustainable and high yielding multi-step chemistry and purification routes in tandem. This will be achieved by combining programmable chemical handling equipment, analytical tools and machine learning.

Dr Mohammed Jeraal and Dr Simon Sung, researchers on the ‘Development of Multi-Step Processes in Pharma’ project. 

 

Data2Knowledge in the Digital Manufacture of Pharmaceuticals

With funding from PIPS via A*STAR

Data2Knowledge in the Digital Manufacture of Pharmaceuticals is led by Professors Alexei Lapkin and Markus Kraft. This is a 15-month project and commenced in December 2020.

Project summary: The digitalisation of chemical manufacturing is one of the critical technology paths towards a more sustainable society, as it promises to deliver a significant level of decarbonisation of industry. It focuses on creating a digital twin of the physical entities that bridges the gap between the cyber- and the real-world, shortening the time span from design to the delivery of the target product to the end-users. Data2Knowledge is a project that aims to develop a fully automated data exchange and knowledge management within a closed-loop self-optimisation experiment.

 

Digital Workflow and Continuous Processing in Pharmaceuticals Manufacturing

With funding from Pfizer as part of PIPS

Digital Workflow and Continuous Processing in Pharmaceuticals Manufacturing is led by Professor Alexei Lapkin. This is a two-year project which commenced in January 2021.

Project summary: Transformation of manufacturing in the pharmaceutical industry to new emerging business models (on demand, customisation, sustainable manufacturing, etc.) is heavily dependent on the development of supporting technologies, such as a novel manufacturing paradigm of fully continuous processes and digital tools for support of R&D and manufacturing. A number of current challenges in the supporting technologies are interlinked. Thus, development of effective flow processes and the use of continuous flow technology in manufacturing requires innovation in process modelling, reactor technology/reactor manufacturing, process data monitoring and knowledge management. This requirement spans the areas of synthesis, process engineering, process control, data science and artificial intelligence.

 

Related Links


C4T Project
CLIC Project
J-Park Simulator
Cities Knowledge Graph
AMPLE
PIPS Project
Knowledge Graph P2P Energy Trading
Cooling Singapore 2.0
CONTACT US

We’ll drop a newsletter every 6 months!



Contact Us

(65) 6601-5445

enquiries@cares.cam.ac.uk

Follow Us

   

Privacy Policy | Terms and Conditions © 2018 Cambridge CARES Ltd
x